(Total Views: 754)
Posted On: 06/02/2020 8:44:30 AM
Post# of 155004
CYTODYN INC. : Form 8-K/A
Filed on Jun 2nd 2020
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 23, 2020, CytoDyn Inc. (the “Company”) filed a Current Report on Form 8-K to announce the appointment of a new independent director, Samir R. Patel, M.D., on April 17, 2020 (the “Original Filing”), to the Company’s Board of Directors (“Board’). At the time of the Original Filing, the Company had not made a determination regarding Board Committee assignments for Dr. Patel.
On May 27, 2020, the Board appointed Dr. Patel to the Board’s Nominating and Governance Committee as its chair.
Other than the preceding disclosure, no other changes have been made to the Original Filing pursuant to this Report.
Filed on Jun 2nd 2020
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 23, 2020, CytoDyn Inc. (the “Company”) filed a Current Report on Form 8-K to announce the appointment of a new independent director, Samir R. Patel, M.D., on April 17, 2020 (the “Original Filing”), to the Company’s Board of Directors (“Board’). At the time of the Original Filing, the Company had not made a determination regarding Board Committee assignments for Dr. Patel.
On May 27, 2020, the Board appointed Dr. Patel to the Board’s Nominating and Governance Committee as its chair.
Other than the preceding disclosure, no other changes have been made to the Original Filing pursuant to this Report.
(0)
(0)
